1. Academic Validation
  2. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1

Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1

  • J Med Chem. 2011 Jun 9;54(11):3854-65. doi: 10.1021/jm200156c.
Kelly E Duncan 1 Brian R Dempsey Lauren E Killip Jarrett Adams Melanie L Bailey Gilles A Lajoie David W Litchfield Christopher J Brandl Gary S Shaw Brian H Shilton
Affiliations

Affiliation

  • 1 Department of Biochemistry, The University of Western Ontario , London, Ontario N6A 5C1, Canada.
Abstract

Phage panning led to the discovery of a disulfide-cyclized peptide CRYPEVEIC that inhibits PIN1 activity with a K(I) of 0.5 μM. NMR chemical shift perturbation experiments show that cyclic CRYPEVEIC binds to the active site of PIN1. PIN1 residues K63 and R68, which bind the phosphate of substrate Peptides, do not show a significant chemical shift change in response to binding of cyclic CRYPEVEIC, consistent with absence of phosphate on the peptide. Cyclic CRYPEVEIC adopts a stable conformation with the side chains of the Y, P, V, and I residues packed together on one side of the ring. Cyclic CRYPEVEIC in solution exists as a mixture of two species, with a 1:4 cis/trans ratio for the Y-P bond. This mixture is stabilized to a single conformation when bound to PIN1. The constrained structure of cyclic CRYPEVEIC apparently facilitates high affinity binding without the presence of a phosphate group.

Figures
Products